Hepatitis C virus core antigen: A simplified treatment monitoring tool, including for post-treatment relapse.

doi:10.1016/j.jcv.2017.05.007

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Hepatitis C virus core antigen: A simplified treatment monitoring tool, including for post-treatment relapse.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology - 1 Jul 2017

Lamoury François M J, Soker Angelica, Martinez Danica, Hajarizadeh Behzad, Cunningham Evan B, Cunningham Philip, Bruggmann Philip, Foster Graham R, Dalgard Olav, Backmund Markus, Conway Brian, Robaeys Geert, Swan Tracy, Cloherty Gavin, Marks Pip, Grebely Jason, Dore Gregory J, Applegate Tanya L

Abstract excerpt

BACKGROUND: Simple, affordable diagnostic tools are essential to facilitate global hepatitis C virus (HCV) elimination efforts. OBJECTIVES: This study evaluated the clinical performance of core antigen (HCVcAg) assay from plasma samples to monitor HCV treatment efficacy and HCV viral recurrence. STUDY DESIGN: Plasma samples from a study of response-guided pegylated-interferon/ribavirin therapy for people who...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Users

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis C Antigens

Share to Immunoassay

Share to Molecular Diagnostic Techniques

Share to Ribavirin

Share to Sustained Virologic Response

Share to Viral Core Proteins

Share to Viremia

Source

Open in PubMed

Identifiers

PMID: 28521211
DOI: 10.1016/j.jcv.2017.05.007

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Hepatitis C virus core antigen: A simplified treatment monitoring tool, including for post-treatment relapse.PMID 28521211Read ↗

Clinical Utility of a New Automated Hepatitis C Virus Core Antigen Assay for Prediction of Treatment Response in Patients with Chronic Hepatitis C.Semantic proximity Read ↗

Hepatitis C virus core antigen, an earlier and stronger predictor on sustained virological response in patients with genotype 1 HCV infection.Semantic proximity Read ↗

Longitudinal assessment of HCV core antigen kinetics to monitor therapeutic response in the age of DAAs.Semantic proximity Read ↗

Diagnosis and monitoring of HCV infection using the cobas® HCV test for use on the cobas® 6800/8800 systems.Semantic proximity Read ↗

Hepatitis C Virus (HCV) diagnosis, epidemiology and access to treatment in a UK cohortSemantic proximity Read ↗

Clinical utility of hepatitis C virus core antigen (HCVcAg) assay to identify active HCV infection in hemodialysis and renal transplant patients.Semantic proximity Read ↗

COBAS ® AmpliPrep/COBAS ® Taqman ® HCV Quantitative Test, version 2.0: an in vitro test for hepatitis C virus RNA quantification.Semantic proximity Read ↗

Clinical significance of residual viremia detected by two real-time PCR assays for response-guided therapy of HCV genotype 1 infection.Semantic proximity Read ↗

Late Relapse Versus Hepatitis C Virus Reinfection in Patients With Sustained Virologic Response After Sofosbuvir-Based Therapies.Semantic proximity Read ↗

Clinical utility of the ARCHITECT HCV Ag assay for early treatment monitoring in patients with chronic hepatitis C genotype 1 infection.Semantic proximity Read ↗

Real-world utility of HCV core antigen as an alternative to HCV RNA testing: Implications for viral load and genotype.Semantic proximity Read ↗

Characterization of nonrapid virologic response patients infected with HCV genotype 1 who may relapse after standard therapy with peginterferon plus ribavirin.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.